Alamar Biosciences, Inc. ALMR
Set alert
29.85 USD +0.90 +3.13%
As of Nov 3, 2:33 PM ET
29.18 Day range 30.27
18.85 52-week range 39.61
- YTD
- +35.66%
- 1 year
- +35.66%
- Open
- 29.18
- Prev close
- 28.94
- Mkt cap
- 2.06B
- Vol
- 316.87K
- Avg vol
- 557.51K
- EPS
- -1.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.18
- High
- 30.27
- Forward P/E
- -64.05
- Beta
- 0.00
- Short ratio
- 3.53
- Inst. own
- 57.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 30.65
- 200-d avg
- 26.93
- 1y target
- 35.40
MAX chart
Events in this range
- May 8, 2026Earnings: -1.74; estimate -1.71; surprise -1.75%
- May 12, 2026Rating: Stifel · — → Buy
- May 12, 2026Rating: JP Morgan · — → Overweight
- May 12, 2026Rating: TD Cowen · — → Buy
- May 12, 2026Rating: Leerink Partners · — → Outperform
- Aug 10, 2026Earnings: -0.22; estimate -0.30787; surprise 28.54%
- Aug 11, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 11, 2026Rating: Stifel · Buy → Buy
- Nov 3, 2026Earnings: —; estimate -0.2015; surprise —%
Signals (47)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
Newest 20 of 47.
Financial health
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -48.9×
FY 2024 5y median -24.4× FY 2025
P/S 19.7×
FY 2024 5y median 9.9× FY 2025
P/B -9.2×
FY 2024 5y median -4.6× FY 2025
P/FCF -24.4×
FY 2024 5y median -12.2× FY 2025
EV/EBITDA -59.3×
FY 2024 5y median -29.6× FY 2025
EV/Sales 19.9×
FY 2024 5y median 9.9× FY 2025
FCF Yield -4.1%
FY 2024 5y median -2.0% FY 2025
Profitability
Gross Margin 56.2%
FY 2024 5y median 28.1% FY 2025
Operating Margin -42.2%
FY 2024 5y median -21.1% FY 2025
Net Margin -40.2%
FY 2024 5y median -20.1% FY 2025
ROE 18.8%
FY 2024 5y median 9.4% FY 2025
ROIC -26.5%
FY 2024 5y median -13.2% FY 2025
ROA -21.3%
FY 2024 5y median -10.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income 0.0%
FY 2024 FY 2025
EPS (diluted) 0.0%
FY 2024 FY 2025
Free Cash Flow 0.0%
FY 2024 FY 2025
Financial Health
Current Ratio 4.0×
FY 2024 5y median 5.2× FY 2025
Quick Ratio 2.4×
FY 2024 5y median 4.0× FY 2025
Debt / Equity -0.3×
FY 2024 5y median -0.3× FY 2025
Net Debt / EBITDA -0.5×
FY 2024 5y median -0.2× FY 2025
Interest Coverage -78.1×
FY 2024 5y median -39.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31